Abstract: A server system obtains a transcription of content from a video and applies a machine learning resource to identify entities which are most likely to be searched for by a user viewing the video, based on the transcription of the content. The server system generates entity cards for each of the entities, each of the entity cards including descriptive content relating to a respective entity among the entities. The server system provides a user interface, to be displayed on a respective display of one or more user computing devices, for playing the video on a first portion of the user interface. When the video is played and a first entity among the entities is mentioned in the video, the user interface displays a first entity card on a second portion of the user interface, the first entity card including descriptive content relating to the first entity.

Abstract: The present invention relates to combinations comprising a checkpoint inhibitor and a c-Met inhibitor, Compound 1. The invention also relates to crystalline forms of the free base of Compound 1, as well as crystalline forms of salts of Compound 1, in combination with a checkpoint inhibitor. The invention also relates to pharmaceutical compositions comprising these combinations. The invention further relates to methods of treating cancer by administering Compound 1 as a single agent or a combination described herein.

Abstract: Antibody drug conjugates (ADC's) that bind to CD37 protein and variants thereof are described herein. CD37 exhibits a distinct and limited expression pattern in normal adult tissue(s), and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention in some embodiments provide a therapeutic composition for the treatment of cancer.

Abstract: Antibody drug conjugates (ADC's) that bind to CD37 protein and variants thereof are described herein. CD37 exhibits a distinct and limited expression pattern in normal adult tissue(s), and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention in some embodiments provide a therapeutic composition for the treatment of cancer.

Abstract: Antibody drug conjugates (ADC's) that bind to CD37 protein and variants thereof are described herein. CD37 exhibits a distinct and limited expression pattern in normal adult tissue(s), and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention in some embodiments provide a therapeutic composition for the treatment of cancer.

Abstract: Antibody drug conjugates (ADC's) that bind to CD37 protein and variants thereof are described herein. CD37 exhibits a distinct and limited expression pattern in normal adult tissue(s), and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention in some embodiments provide a therapeutic composition for the treatment of cancer.

Abstract: Antibody drug conjugates (ADC's) that bind to CD37 protein and variants thereof are described herein. CD37 exhibits a distinct and limited expression pattern in normal adult tissue(s), and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention in some embodiments provide a therapeutic composition for the treatment of cancer.

Abstract: EphB3-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating an EphB3-related disease or disorder.

Abstract: A computing device may be joined to a cluster by discovering the device, determining whether the device is eligible to join the cluster, configuring the device, and assigning the device a cluster role. A device may be assigned to act as a cluster master, backup master, active device, standby device, or another role. The cluster master may be configured to assign tasks, such as network flow processing to the cluster devices. The cluster master and backup master may maintain global, run-time synchronization data pertaining to each of the network flows, shared resources, cluster configuration, and the like. The devices within the cluster may monitor one another. Monitoring may include transmitting status messages comprising indicators of device health to the other devices in the cluster. In the event a device satisfies failover conditions, a failover operation to replace the device with another standby device, may be performed.

Abstract: Antibody drug conjugates (ADC's) that bind to CD37 protein and variants thereof are described herein. CD37 exhibits a distinct and limited expression pattern in normal adult tissue(s), and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention in some embodiments provide a therapeutic composition for the treatment of cancer.

Abstract: A computing device may be joined to a cluster by discovering the device, determining whether the device is eligible to join the cluster, configuring the device, and assigning the device a cluster role. A device may be assigned to act as a cluster master, backup master, active device, standby device, or another role. The cluster master may be configured to assign tasks, such as network flow processing to the cluster devices. The cluster master and backup master may maintain global, run-time synchronization data pertaining to each of the network flows, shared resources, cluster configuration, and the like. The devices within the cluster may monitor one another. Monitoring may include transmitting status messages comprising indicators of device health to the other devices in the cluster. In the event a device satisfies failover conditions, a failover operation to replace the device with another standby device, may be performed.

Abstract: EphB3-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating an EphB3-related disease or disorder.

Abstract: EphB3-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating cancer.

Abstract: EphB3-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating an EphB3-related disease or disorder.

Abstract: EphB3-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating cancer.

Abstract: EphB3-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating cancer.

Abstract: Some implementations disclosed herein provide techniques and arrangements to enable interactive zones. For example, some implementations detect that a user has entered a zone associated with a physical object, where the zone is created via magnetic induction. In response to detecting that the user has entered the zone, some implementations send a virtual object representation of the physical object to a user device (e.g., a wireless phone) associated with the user. The user may interact with the virtual object, including selecting a command associated with the virtual object. Selecting the command may cause the physical object to perform one or more actions. In some implementations, a result of the physical object performing the one or more actions is sent to the user device.

Abstract: A computing device may be joined to a cluster by discovering the device, determining whether the device is eligible to join the cluster, configuring the device, and assigning the device a cluster role. A device may be assigned to act as a cluster master, backup master, active device, standby device, or another role. The cluster master may be configured to assign tasks, such as network flow processing to the cluster devices. The cluster master and backup master may maintain global, run-time synchronization data pertaining to each of the network flows, shared resources, cluster configuration, and the like. The devices within the cluster may monitor one another. Monitoring may include transmitting status messages comprising indicators of device health to the other devices in the cluster. In the event a device satisfies failover conditions, a failover operation to replace the device with another standby device, may be performed.

Abstract: EphB3-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating an EphB3-related disease or disorder.

Abstract: A computing device may be joined to a cluster by discovering the device, determining whether the device is eligible to join the cluster, configuring the device, and assigning the device a cluster role. A device may be assigned to act as a cluster master, backup master, active device, standby device, or another role. The cluster master may be configured to assign tasks, such as network flow processing to the cluster devices. The cluster master and backup master may maintain global, run-time synchronization data pertaining to each of the network flows, shared resources, cluster configuration, and the like. The devices within the cluster may monitor one another. Monitoring may include transmitting status messages comprising indicators of device health to the other devices in the cluster. In the event a device satisfies failover conditions, a failover operation to replace the device with another standby device, may be performed.